Literature DB >> 15563491

Pyrosequencing method for genotyping cytochrome P450 CYP2C8 and CYP2C9 enzymes.

Matthew W Hruska1, Reginald F Frye, Taimour Y Langaee.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15563491     DOI： 10.1373/clinchem.2004.040071

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  11 in total

1.  Decreased warfarin clearance associated with the CYP2C9 R150H (*8) polymorphism.

Authors:  Y Liu; H Jeong; H Takahashi; K Drozda; S R Patel; N L Shapiro; E A Nutescu; L H Cavallari
Journal:  Clin Pharmacol Ther       Date:  2012-02-29       Impact factor: 6.875

2.  Ethnicity-specific pharmacogenetics: the case of warfarin in African Americans.

Authors:  W Hernandez; E R Gamazon; K Aquino-Michaels; S Patel; T J O'Brien; A F Harralson; R A Kittles; A Barbour; M Tuck; S D McIntosh; J N Douglas; D Nicolae; L H Cavallari; M A Perera
Journal:  Pharmacogenomics J       Date:  2013-09-10       Impact factor: 3.550

3.  Population differences in S-warfarin pharmacokinetics among African Americans, Asians and whites: their influence on pharmacogenetic dosing algorithms.

Authors:  K Kubo; M Ohara; M Tachikawa; L H Cavallari; M T M Lee; M S Wen; M G Scordo; E A Nutescu; M A Perera; A Miyajima; N Kaneko; V Pengo; R Padrini; Y T Chen; H Takahashi
Journal:  Pharmacogenomics J       Date:  2016-08-09       Impact factor: 3.550

4.  Integrated analysis of genetic variation and gene expression reveals novel variant for increased warfarin dose requirement in African Americans.

Authors:  W Hernandez; E R Gamazon; K Aquino-Michaels; E Smithberger; T J O'Brien; A F Harralson; M Tuck; A Barbour; L H Cavallari; M A Perera
Journal:  J Thromb Haemost       Date:  2017-03-25       Impact factor: 5.824

5.  Differences in Warfarin Pharmacodynamics and Predictors of Response Among Three Racial Populations.

Authors:  Minami Ohara; Yasuhiko Suzuki; Saki Shinohara; Inna Y Gong; Crystal L Schmerk; Rommel G Tirona; Ute I Schwarz; Ming-Shien Wen; Ming Ta Michael Lee; Kiyoshi Mihara; Edith A Nutescu; Minoli A Perera; Larisa H Cavallari; Richard B Kim; Harumi Takahashi
Journal:  Clin Pharmacokinet       Date:  2019-08       Impact factor: 6.447

6.  Association of the GGCX (CAA)16/17 repeat polymorphism with higher warfarin dose requirements in African Americans.

Authors:  Larisa H Cavallari; Minoli Perera; Mia Wadelius; Panos Deloukas; Gelson Taube; Shitalben R Patel; Keston Aquino-Michaels; Marlos A G Viana; Nancy L Shapiro; Edith A Nutescu
Journal:  Pharmacogenet Genomics       Date:  2012-02       Impact factor: 2.089

7.  Novel single nucleotide polymorphism in CYP2C9 is associated with changes in warfarin clearance and CYP2C9 expression levels in African Americans.

Authors:  Wenndy Hernandez; Keston Aquino-Michaels; Katarzyna Drozda; Shitalban Patel; Young Jeong; Harumi Takahashi; Larisa H Cavallari; Minoli A Perera
Journal:  Transl Res       Date:  2014-11-22       Impact factor: 7.012

8.  Predictors of unstable anticoagulation in African Americans.

Authors:  Larisa H Cavallari; Jonathan L Aston; Kathryn M Momary; Nancy L Shapiro; Shitalben R Patel; Edith A Nutescu
Journal:  J Thromb Thrombolysis       Date:  2008-06-19       Impact factor: 2.300

9.  Effect of NQO1 and CYP4F2 genotypes on warfarin dose requirements in Hispanic-Americans and African-Americans.

Authors:  Adam Bress; Shitalben R Patel; Minoli A Perera; Richard T Campbell; Rick A Kittles; Larisa H Cavallari
Journal:  Pharmacogenomics       Date:  2012-12       Impact factor: 2.533

10.  Feasibility of implementing a comprehensive warfarin pharmacogenetics service.

Authors:  Edith A Nutescu; Katarzyna Drozda; Adam P Bress; William L Galanter; James Stevenson; Thomas D Stamos; Ankit A Desai; Julio D Duarte; Victor Gordeuk; David Peace; Shrihari S Kadkol; Carol Dodge; Santosh Saraf; John Garofalo; Jerry A Krishnan; Joe G N Garcia; Larisa H Cavallari
Journal:  Pharmacotherapy       Date:  2013-07-17       Impact factor: 4.705
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.